Moran Kevin Patrick
SEC insider (Form 3/4/5 filer). CIK 0001806596. SVP, CFO & Treasurer at Vanda Pharmaceuticals Inc. (VNDA). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in WASHINGTON, DC.
Companies Moran Kevin Patrick has filed insider reports for
- Vanda Pharmaceuticals Inc. (VNDA): Officer, SVP, CFO & Treasurer
Moran Kevin Patrick
CIK: 0001806596
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VNDA
Vanda Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 2, 2026VNDA
Vanda Pharmaceuticals Inc.
SaleDirect42.4K shares at avg. $8.27$351K - Feb 18, 2026VNDA
Vanda Pharmaceuticals Inc.
AwardDirect125K shares- - Mar 1, 2025VNDA
Vanda Pharmaceuticals Inc.
Tax PaymentDirect26.9K shares at avg. $4.76$128K - Feb 21, 2025VNDA
Vanda Pharmaceuticals Inc.
PurchaseDirect2K shares at avg. $4.39$9K - Feb 18, 2025VNDA
Vanda Pharmaceuticals Inc.
AwardDirect125K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | VNDA Vanda Pharmaceuticals Inc. | Sale | 42,442 | $8.27 | $350,821 | Direct |
| Feb 18, 2026 | VNDA Vanda Pharmaceuticals Inc. | Award | 125,000 | - | $0 | Direct |
| Mar 1, 2025 | VNDA Vanda Pharmaceuticals Inc. | Tax Payment | 26,941 | $4.76 | $128,239 | Direct |
| Feb 21, 2025 | VNDA Vanda Pharmaceuticals Inc. | Purchase | 2,000 | $4.39 | $8,779 | Direct |
| Feb 18, 2025 | VNDA Vanda Pharmaceuticals Inc. | Award | 125,000 | - | - | Direct |
1-5 of 5 transactions